Rendering

Component: (Network and Table)
Network
100340 - Disclosure - Income Taxes (Tables)
(http://www.acorda.com/20161231/taxonomy/role/DisclosureIncomeTaxesTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Income Tax Disclosure [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Income Tax Disclosure [Abstract]
 
Schedule of Domestic and Foreign Components of (Loss) Income Before Income Taxes

 

(In thousands)

 

Year ended

December 31,

2016

 

 

Year ended

December 31,

2015

 

 

Year ended

December 31,

2014

 

Domestic

 

$

(36,454

)

 

$

16,284

 

 

$

25,679

 

Foreign

 

 

(5,814

)

 

 

3,085

 

 

 

2,330

 

Total

 

$

(42,268

)

 

$

19,369

 

 

$

28,009

 

 

 
 
Schedule of Benefit from (Provision for) Income Taxes

 

(In thousands)

 

Year ended

December 31,

2016

 

 

Year ended

December 31,

2015

 

 

Year ended

December 31,

2014

 

Current:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(852

)

 

$

(603

)

 

$

(1,105

)

State

 

 

(4,517

)

 

 

(2,773

)

 

 

(1,819

)

Foreign

 

 

781

 

 

 

(960

)

 

 

(732

)

 

 

 

(4,588

)

 

 

(4,336

)

 

 

(3,656

)

Deferred:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

9,465

 

 

 

(2,960

)

 

 

(6,085

)

State

 

 

1,788

 

 

 

(1,015

)

 

 

(596

)

Foreign

 

 

 

 

 

 

 

 

 

 

 

 

11,253

 

 

 

(3,975

)

 

 

(6,681

)

Total benefit from (provision for) income taxes

 

$

6,665

 

 

$

(8,311

)

 

$

(10,337

)

 

 
 
Schedule of Reconciliation of the Statutory U.S. Federal Income Tax Rate to the Entity's Effective Income Tax Rate

 

 

 

Year ended

December 31,

2016

 

 

Year ended

December 31,

2015

 

 

Year ended

December 31,

2014

 

U.S. federal statutory tax rate

 

 

35.0

%

 

 

35.0

%

 

 

35.0

%

State and local income taxes

 

 

(3.8

)%

 

 

13.3

%

 

 

3.7

%

Non-deductible payment to prior shareholders

 

 

 

 

 

15.8

%

 

 

 

Foreign income tax

 

 

1.2

%

 

 

3.2

%

 

 

1.8

%

Stock option compensation

 

 

(3.8

)%

 

 

10.4

%

 

 

4.8

%

Stock option shortfall

 

 

(6.5

)%

 

 

 

 

 

 

Research and development and orphan drug credits

 

 

28.9

%

 

 

(42.9

)%

 

 

(15.5

)%

Increase to Uncertain Tax Positions

 

 

(4.8

)%

 

 

7.1

%

 

 

2.3

%

Other nondeductible and permanent differences

 

 

(1.1

)%

 

 

1.9

%

 

 

2.6

%

Valuation allowance

 

 

(31.6

)%

 

 

(0.9

)%

 

 

2.2

%

Transaction Cost

 

 

(5.9

)%

 

 

 

 

 

 

Gain or Loss on Hedging

 

 

8.2

%

 

 

 

 

 

 

Effective income tax rate

 

 

15.8

%

 

 

42.9

%

 

 

36.9

%

 

 
 
Schedule of Deferred Tax Assets and Liabilities

 

(In thousands)

 

December 31,

2016

 

 

December 31,

2015

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating loss and other carryforwards

 

$

97,391

 

 

$

60,889

 

Tax credits

 

 

35,489

 

 

 

20,778

 

Deferred revenue

 

 

11,672

 

 

 

13,949

 

Stock based compensation

 

 

34,700

 

 

 

27,142

 

Contingent consideration

 

 

26,543

 

 

 

23,298

 

Employee compensation

 

 

6,116

 

 

 

5,603

 

Legal reserve

 

 

2,707

 

 

 

 

Rebate and returns reserve

 

 

7,582

 

 

 

4,994

 

Capitalized R&D

 

 

10,025

 

 

 

 

Other

 

 

4,096

 

 

 

3,126

 

Total deferred tax assets

 

$

236,321

 

 

$

159,779

 

Valuation allowance

 

$

(63,225

)

 

$

(5,277

)

Total deferred tax assets net of valuation allowance

 

$

173,096

 

 

$

154,502

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Intangible assets

 

 

(245,500

)

 

 

(145,433

)

Convertible debt

 

 

(16,003

)

 

 

(19,087

)

Total deferred tax liabilities

 

$

(261,503

)

 

$

(164,520

)

Net deferred tax liability

 

$

(88,407

)

 

$

(10,018

)

 

 
 
Schedule of Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits

 

(In thousands)

 

Year ended

December 31,

2016

 

 

Year ended

December 31,

2015

 

 

Year ended

December 31,

2014

 

Beginning of period balance

 

$

4,835

 

 

$

3,295

 

 

$

2,244

 

Increases for tax positions taken during a prior period

 

 

570

 

 

 

308

 

 

 

451

 

Decreases for tax positions taken during a prior period

 

 

 

 

 

 

 

 

(200

)

Increases for tax positions taken during the current period

 

 

1,451

 

 

 

1,232

 

 

 

800

 

Reduction as a result of a lapse of statute of limitations

 

 

 

 

 

 

 

 

 

 

 

$

6,856

 

 

$

4,835

 

 

$

3,295